51客服
分类查询
 
会员登录
 
登录账号:
登录密码:
验 证 码:
您好,您已登录
您有条新到站内短信
会员中心 退出登录
发布于:2018-11-9 09:41:02  访问:24 次 回复:0 篇
版主管理 | 推荐 | 删除 | 删除并扣分
S KM, Solomon B, Pearson RB, Phillips WA: Targeting PI3 Kinase
Shafee N, Kaluz S, Ru N, Stanbridge EJ: PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett 2009, 282(1):109?15. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C: Regulation of hypoxia-inducible factor-1alpha protein level in the course of hypoxic circumstances by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem 2003, 278(33):31277?1285. O‘Brien D, Jacob AG, Qualman SJ, Chandler DS: Advances in pediatric rhabdomyosarcoma characterization and disease model development. Histol Histopathol 2012, 27(1):13?2. Karosas AO: Ewing‘s sarcoma. Am J Overall health Syst Pharm 2010, 67(19):1599?605. Scotlandi K: Targeted therapies in Ewing‘s sarcoma. Adv Exp Med Biol 2006, 587:13?2. Wachtel M, Schafer BW: Targets for cancer therapy in childhood sarcomas. Cancer Treat Rev 2010, 36(4):318?27. Opel D, Poremba C, Simon T, Debatin KM, Fulda S: Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 2007, 67(2):735?45. Cen L, Hsieh FC, Lin HJ, Chen CS, Qualman SJ, Lin J: PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells employing OSU-03012 compound. Br J Cancer 2007, 97(six):785?91. Petricoin EF 3rd, Espina V, Araujo RP, Midura B, Yeung C, Wan X, MedChemExpress GS-7340 (hemifumarate) Eichler GS, Johann DJ Jr, Qualman S, Tsokos M, et al: Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively related to childhood rhabdomyosarcoma survival. Cancer Res 2007, 67(7):3431?440. Ahmed AA, Sherman AK, Pawel BR: Expression of therapeutic targets in Ewing sarcoma household tumors. Hum Pathol 2012, 43(7):1077?083. Opel D, Naumann I, Schneider M, Bertele D, Debatin KM, Fulda S: Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Clin Cancer Res 2011, 17(10):3233?247. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A: Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 2007, 18(12):4691?697. Ardyanto TD, Osaki M, Tokuyasu N, Nagahama Y, Ito H: CoCl2-induced HIF-1alpha expression correlates with proliferation and apoptosis in MKN-1 cells: a doable part for the PI3K/Akt pathway. Int J Oncol 2006, 29(3):549?55.S KM, Solomon B, Pearson RB, Phillips WA: Targeting PI3 Kinase/AKT/mTOR Signaling in Cancer. Crit Rev Oncog 2012, 17(1):69?5. Chen Y, Wang BC, Xiao Y: PI3K: A possible therapeutic target for PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26740125 cancer. J Cell Physiol 2012, 227(7):2818?821. Fulda S: The PI3K/Akt/mTOR pathway as therapeutic target in neuroblastoma. Curr Cancer Drug Targets 2009, 9(6):729?37. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL: Modulation of hypoxia-inducible aspect 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/ FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000, 60(6):1541?545.
共0篇回复 每页10篇 页次:1/1
共0篇回复 每页10篇 页次:1/1
我要回复
回复内容
验 证 码
看不清?更换一张
匿名发表 
脚注信息
© Copyright 2012. 版权所有北京中矿基业安全防范技术有限公司
访问统计